close

News WrapGet Handpicked Stories from our editors directly to your mailbox

Share to buy: Sun Pharma set to give 11 pct returns in one month, say experts

Sun Pharma stock has validated the Hammer candle pattern formed on the weekly chart (moved above candle’s high) which is confirmation of the bullish reversal.

Share to buy: Sun Pharma set to give 11 pct returns in one month, say experts
Exponential moving average of the Sun Pharma shares is indicating an upside momentum while its RSI Positive Divergence is also supporting the bull run in the pharma counter. Photo: Pixabay
Written By: Asit Manohar
Updated: Thu, Jun 27, 2019
05:18 pm
New Delhi, ZeeBiz WebDesk
RELATED NEWS
Anil Singhvi’s Strategy September 6: Market Trend is Neutral; Metal sector is Positive; NBFC is Negative Anil Singhvi’s Strategy September 6: Market Trend is Neutral; Metal sector is Positive; NBFC is Negative
Stocks in Focus on September 6: Sun Pharma, Reliance Industries to Tech Mahindra; here are the 5 Newsmakers of the Day Stocks in Focus on September 6: Sun Pharma, Reliance Industries to Tech Mahindra; here are the 5 Newsmakers of the Day
Anil Singhvi’s Strategy September 4: Market Trend & Sentiment are Negative; Sell Sun Pharma Futures with Stop Loss 445 Anil Singhvi’s Strategy September 4: Market Trend & Sentiment are Negative; Sell Sun Pharma Futures with Stop Loss 445
Stocks in Focus on September 4: Sun Pharma, Aditya Birla Capital to Varun Beverages; here are the 5 Newsmakers of the Day Stocks in Focus on September 4: Sun Pharma, Aditya Birla Capital to Varun Beverages; here are the 5 Newsmakers of the Day
Sensex scales on ease in China-US trade tension, Nifty regains 11K; Tata Steel, Vodafone Idea, Sun Pharma stocks gain Sensex scales on ease in China-US trade tension, Nifty regains 11K; Tata Steel, Vodafone Idea, Sun Pharma stocks gain

Sun Pharma share price is expected to deliver around 11 per cent returns if a stock market investor decides to buy the stock at its current levels of around Rs 400 per share. Stock market experts are of the opinion that Sun Pharma stocks' 21 days exponential moving average indicates an upside momentum while its RSI positive divergence is also promising for the traders. Experts are of the opinion that the counter may show Rs 445 per stock levels in short-term perspective means in around one-month period. 

Speaking on the short-term technical outlook of the Sun Pharma share price Gajendra Prabu, Technical Research Analyst, HDFC Securities said, "The stock has validated the Hammer candle pattern formed on the weekly chart (moved above candle’s high) which is confirmation of the bullish reversal. Price has provided a breakout of key short term trendline. Price has started to form a higher top and higher bottom on intraday charts which is a bullish development. In addition, technical indicators are placed in favour of bulls; this could add strength to bulls." 

See Zee Business video below:

On the suggestion to the stock market investors, Gajendra Prabu of HDFC securities said, "Traders may look to buy the stock at CMP and add on dips to Rs 385 for the upside target of Rs 445 over the next 2-3 weeks. Place a stop loss at Rs 377."

Giving details of the fundamentals of Sun Pharma counter Prakash Pandey, Head of Research at Fairwealth Securities said, "Exponential moving average of the Sun Pharma shares is indicating an upside momentum while its RSI Positive Divergence is also supporting the bull run in the pharma counter. I would suggest stock market investors take a buy position in the counter for around 10-12 per cent gains in short-term means around one-month time period."